Distinctive gene expression profiles associated with Hepatitis B virus x protein.

Area of Science:

• Hepatology and Oncology
• Molecular Biology
• Gene Expression Profiling

Background:

• Hepatitis B virus (HBV) is a primary risk factor for hepatocellular carcinoma (HCC).
• The HBV-encoded HBx protein is a potential oncogene involved in gene deregulation, but its role in early HCC genesis is unclear.

Purpose of the Study:

• To investigate the role of HBx in the early stages of HCC development.
• To analyze gene expression profiles in hepatocytes and liver tissues related to HBx expression and HBV infection.

Main Methods:

• Utilized NCI Oncochip microarray (2208 human cDNA clones) to examine gene expression in HBx-expressing primary human hepatocytes (Hhep) and an HCC cell line (SK-Hep-1).
• Analyzed gene expression in liver samples from chronic active hepatitis patients compared to normal liver samples.
• Validated microarray results using Northern blot analysis.

Main Results:

• Gene expression profiling revealed consistent alterations in cellular genes, including oncogenes (c-myc, c-myb) and tumor suppressor genes (APC, p53, WAF1, WT1), in HBx-expressing hepatocytes and HBV-infected liver samples.
• Distinctive gene expression profiles were observed between normal Hhep and SK-Hep-1 cells.
• Microarray reproducibility was confirmed through scatterplot analysis.

Conclusions:

• HBx-mediated deregulation of cellular genes, affecting oncogenes and tumor suppressors, is a potential early event in liver carcinogenesis.
• This deregulation may promote hepatocyte proliferation, contributing to HCC development.